Tong Yang

Tong Yang

Auto-generated profile, based on publicly available information

Tong Yang

Department of Infectious Disease Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science , Beijing 100071

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
JXJinyan Xie
Jinyan Xie
Hao LiHao Li
Hao Li
XZXiaoai Zhang
Xiaoai Zhang
TYTong Yang
Tong Yang
MYMengjia Yue
Mengjia Yue
WLWei Liu
Wei Liu

20 November 2020 in Reviews in Medical Virology
Verified
Journal Article
Open access
PDF file
KLKun Liu
Kun Liu
TYTong Yang
Tong Yang
XPXue‐Fang Peng
Xue‐Fang Peng
SLShou‐Ming Lv
Shou‐Ming Lv
XYXiao‐Lei Ye
Xiao‐Lei Ye
WLWei Liu
Wei Liu
Summary: Currently severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission has been on the rise worldwide. Predicting outcome in COVID‐19 remains challenging, and the search for more robust predictors continues. We made a systematic meta‐analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of disease severity were determined as well. A total of 149 distinct studies that evaluated ten cytokines, four antibodies, four T cells, B cells, NK cells, neutrophils, monocytes, eosinophils and basophils were included. Compared with the non‐severe patients of COVID‐19, serum levels of Interleukins (IL)‐2, IL‐2R, IL‐4, IL‐6, IL‐8, IL‐10 and tumor necrosis factor α were significantly up‐regulated in severe patients, with the largest inter‐group differences observed for IL‐6 and IL‐10. In contrast, IL‐5, IL‐1β and Interferon (IFN)‐γ did not show significant inter‐group difference. Four mediators of T cells count, including CD3+ T, CD4+ T, CD8+ T, CD4+CD25+CD127‐ Treg, together with CD19+ B cells count and CD16+CD56+ NK cells were all consistently and significantly depressed in severe group than in non‐severe group. SARS‐CoV‐2 specific IgA and IgG antibodies were significantly higher in severe group than in non‐severe group, while IgM antibody in the severe patients was slightly lower than those in the non‐severe patients, and IgE antibody showed no significant inter‐group differences. The combination of cytokines, especially IL‐6 and IL‐10, and T cell related immune signatures can be used as robust biomarkers to predict disease severity following SARS‐CoV‐2 infection.

18 September 2024 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
XZXiaojie Zheng
Xiaojie Zheng
YZYunfa Zhang
Yunfa Zhang
LZLingyu Zhang
Lingyu Zhang
TYTong Yang
Tong Yang
FZFaxue Zhang
Faxue Zhang
WLWei Liu
Wei Liu

1 October 2017 in Gene
Verified
Journal Article
Closed access
ZDZimei Dong
Zimei Dong
TYTong Yang
Tong Yang
YYYibo Yang
Yibo Yang
HDHe Dou
He Dou
GCGuangwen Chen
Guangwen Chen

29 October 2024 in Protein & Cell
Verified
Journal Article
Open access
PDF file
SLShuang Li
Shuang Li
XZXiaojie Zheng
Xiaojie Zheng
YZYunfa Zhang
Yunfa Zhang
LZLingyu Zhang
Lingyu Zhang
TYTong Yang
Tong Yang
WLWei Liu
Wei Liu
Shuang Li, Xiaojie Zheng, Yunfa Zhang, Lingyu Zhang, Tong Yang, Hao Li, Caiyu Zhou, Xiao-Ai Zhang, Li-Zeng Gao, Wei Liu; Antiviral activity of lipoxygenase